GlassScriptPhysician profile
Sarah Shapiro
NPI 1841984598
$2,234.23
in general payments reported to CMS, 2019-2025
41 companies · $818 in 2025
The $818 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $346 · 2024: $1,071 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,234.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $290.53 | 2023-2025 | Enhertu, Vanflyta, Datroway |
| Janssen Biotech, INC. | $133.50 | 2023-2025 | Erleada, Carvykti, Talvey |
| Astrazeneca Pharmaceuticals LP | $127.44 | 2024-2025 | Tagrisso, Imfinzi, Lynparza |
| Merck Sharp & Dohme LLC | $124.87 | 2023-2025 | Keytruda, Lynparza |
| Regeneron Healthcare Solutions, INC. | $122.10 | 2023-2024 | Libtayo |
| Pfizer INC. | $94.18 | 2023-2025 | |
| Genentech USA, INC. | $86.93 | 2024-2025 | Venclexta, Itovebi |
| Bayer Healthcare Pharmaceuticals INC. | $84.64 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $75.02 | 2024-2025 | |
| Incyte Corporation | $64.95 | 2023-2025 | Jakafi, Monjuvi, Zynyz |
| Takeda Pharmaceuticals U.S.A., INC. | $64.16 | 2023-2024 | Ninlaro, Fruzaqla |
| Abbvie INC. | $60.46 | 2024-2025 | |
| Exelixis INC. | $59.10 | 2023-2025 | Cabometyx |
| Alexion Pharmaceuticals, INC. | $55.90 | 2024-2025 | Ultomiris |
| Celgene Corporation | $51.75 | 2024 | Reblozyl |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.